The receptor tyrosine kinase-like orphan receptor 1 (ROR1) is highly expressed in CLL but not in normal B cells, implying that its targeting by CARs should lead to tumor cell-specific elimination. Here, ROR1 is linked to B-cell chronic lymphocytic leukemia.